Product Information
CARBAMAZEPINE 200 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1190 per EA under NDC 75834022100. Its NADAC has been published 318 times since Jul 22, 2020.
FDA first approved this application on Apr 15, 2020. Its Orange Book therapeutic-equivalence code is BX.
Strength
200 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834022100
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA207798FDA Approved
4/15/2020
TE Code
BX
On Market Since
4/21/2020
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE 200 MG TABLET has been published 318 times since Jul 22, 2020, and over the history we have for it it has declined 63.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1190 per EA |
|---|---|
| All-time high | $0.3238 (Aug 12, 2020) |
| All-time low | $0.1005 (Jul 17, 2024) |
| 52-week high | $0.1261 |
| 52-week low | $0.1157 |
| Median price | $0.1577 |
| Average price | $0.1799 |
| Largest weekly change | +96.7% (Aug 28, 2024) |
| Weeks tracked | 318 |
| Tracking since | Jul 22, 2020 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 200 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1190 per EA (NDC 75834022100), effective Aug 19, 2026.
How has the price of CARBAMAZEPINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE 200 MG TABLET has declined 63.2%. It has been tracked across 318 weekly CMS publications since Jul 22, 2020.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 200 MG TABLET?
Since Jul 22, 2020, the NADAC for CARBAMAZEPINE 200 MG TABLET has ranged from a low of $0.1005 (Jul 17, 2024) to a high of $0.3238 (Aug 12, 2020), with a median of $0.1577 per EA.
Are there cheaper alternatives to CARBAMAZEPINE 200 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBAMAZEPINE 200 MG TABLET, is $0.1170 per EA — about 2% below CARBAMAZEPINE 200 MG TABLET.
Who manufactures CARBAMAZEPINE 200 MG TABLET?
CARBAMAZEPINE 200 MG TABLET (NDC 75834022100) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.